Treatment of low-grade oligodendroglial tumors without radiotherapy
Abstract
The authors prospectively treated 18 consecutive patients with low-grade oligodendroglial tumors without postoperative radiotherapy. The treatment strategy was as follows: follow-up after total resection and chemotherapy after subtotal resection or biopsy. All patients were alive and 17 patients (94%) were progression-free after a median follow-up of 4.7 years. The results suggested that radiotherapy could be postponed until clinical progression in the treatment of low-grade oligodendroglial tumors.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000; 54: 1442–1448.
2.
Lindegaard KF, Mork SJ, Eide GE, et al. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg. 1987; 67: 224–230.
3.
Shaw EG, Scheithauer BW, O’Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg. 1992; 76: 428–434.
4.
Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery. 1994; 35: 1018–1034.
5.
Yeh SA, Lee TC, Chen HJ, et al. Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma. Int J Radiat Oncol Biol Phys. 2002; 54: 1405–1409.
6.
Mason WP, Krol GS, DeAngelis LM. Low-grade oligodendroglioma responds to chemotherapy. Neurology. 1996; 46: 203–207.
7.
Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996; 36: 549–556.
8.
Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002; 20: 2267–2276.
9.
Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys. 2002; 52: 316–324.
10.
Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998; 90: 1473–1479.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Received: March 22, 2004
Accepted: August 2, 2004
Published online: December 28, 2004
Published in print: December 28, 2004
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma, Journal of Neuro-Oncology, 153, 3, (447-454), (2021).https://doi.org/10.1007/s11060-021-03781-z
- Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?, Current Opinion in Neurology, 33, 6, (707-715), (2020).https://doi.org/10.1097/WCO.0000000000000866
- Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas, PLOS ONE, 13, 9, (e0203639), (2018).https://doi.org/10.1371/journal.pone.0203639
- Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade, Journal of Neuro-Oncology, 141, 1, (205-211), (2018).https://doi.org/10.1007/s11060-018-03027-5
- Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas, PLOS ONE, 12, 6, (e0178552), (2017).https://doi.org/10.1371/journal.pone.0178552
- Chemotherapy for Diffuse Low Grade Gliomas, Diffuse Low-Grade Gliomas in Adults, (535-577), (2017).https://doi.org/10.1007/978-3-319-55466-2_25
- Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11 C-methionine positron emission tomography , Journal of Neurology, Neurosurgery & Psychiatry, 87, 9, (1016-1021), (2016).https://doi.org/10.1136/jnnp-2015-311516
- Prognostic factors for low-grade diffuse gliomas and approaches to their treatment, Onkologiya. Zhurnal imeni P.A.Gertsena, 4, 6, (83), (2015).https://doi.org/10.17116/onkolog20154683-89
- Extreme protraction for low-grade gliomas: theoretical proof of concept of a novel therapeutical strategy, Mathematical Medicine and Biology, 33, 3, (253-271), (2015).https://doi.org/10.1093/imammb/dqv017
- Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?, Seminars in Radiation Oncology, 25, 3, (203-209), (2015).https://doi.org/10.1016/j.semradonc.2015.02.008
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.